P111 - Sunitinib treatment modification in metastatic renal cell carcinoma – the impact of 2/1 dosing schedule and dose reduction in survival outcomes
| Autor: | Valente, A.D.C., J. Costa, M., Nogueira Costa, I., Reis, J., Baptista Freitas, M., Lopes Almeida, C., Teixeira, C., Veloso Gonçalves, M., Ribeiro, M.J., Meireles, S., Barbosa, M., Augusto, I. |
|---|---|
| Zdroj: | In European Urology Open Science November 2022 45 Supplement 2:S194-S194 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|